Welcome to OVEA!
Clinical Trials Matching For Ovarian Cancer Community
Let us walk with you and assist you on your search.
We are here to help you and your loved ones make informed decisions
and choices about your health care needs.
Research will ultimately cure ovarian cancer. Clinical trials are research studies via which researchers determine if a new form of treatment or prevention, such as a new drug, diet, or medical device is safe and effective. We invite you to explore the latest advancements and clinical trials in ovarian cancer. With the help of OVEA, be empowered to:
- Know and learn about your options
- Access the latest available treatments
- Receive carefully guided and monitored world class care
Let’s discover the power of clinical trials
as we Ovarcome together!
I am OVEA, and I look forward to helping you find your match!
Please watch the following videos to learn more about clinical trials and to optimize your search.
Heading Explainer Video:
Heading Explainer Video:
You may also read the FAQs here
on any trial on the clinicaltrials.gov website
Featured Clinical Trials
Explore the latest in ovarian cancer research studies
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This phase I/IIa trial studies the side effects and best dose of a type of specialized immune cell (natural killer cell-like cytotoxic T-lymphocytes (CTLs) (nCTLs) and how well they work when given wi...
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wear...
Assessing the Time Demands of Cancer
A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry t...
Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer
This phase I/II trial tests the safety, side effects and best dose of a combination therapy (niraparib and selenium) in treating patients with BRCA negative ovarian cancer that has come back (recurren...
Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer
The purpose of this study is to find out if a new drug, M4344, is safe and has beneficial effects when given in combination with the PARP inhibitor, Niraparib, in women with recurrent ovarian cancer t...
Hello, my name is Kristin Johnson, and I am your Clinical Trials Navigator. I have been an oncology nurse for 15 years. I have a BS in Genetics from Texas A&M University, a BS in Nursing from the University of Texas Health Science Center, and an MSN in Nursing Administration from UT Arlington. My oncology nursing experience has been at MD Anderson Cancer Center in the Gynecologic Oncology Department, in both inpatient and outpatient roles. My most recent role was as a Clinical Research Nurse. I have been involved as a volunteer with Ovarcome for many years. My mom Betty White is on the board and is a 25-year survivor of ovarian cancer. I look forward to answering questions and helping patients and caregivers gather information about ovarian cancer clinical trials.
Let’s Ovarcome Together!
Our Clinical Trials Program FInder is made possible by
We Need Your Help
Volunteer with us.